Search

Robert L Lowsky

from Belmont, CA
Age ~64
Get Report
Related to:
Emma Lowsky, 31Brenda L Strangemore, 63
Connected to:
Martin J Lowsky, 71Linda M Lowson, 73Michael S Lowson, 35Eric R Lowstuter, 42Antionette Lowther, 37Audrey Lowther, 99Billy J Lowther, 76Britnee N Lowther, 34Bruce W Lowther, 57Cameron J Lowther, 33

Robert Lowsky Phones & Addresses

  • 2205 Semeria Ave, Belmont, CA 94002
  • Redwood City, CA
  • 2363 Branner Dr, Menlo Park, CA 94025
  • Palo Alto, CA
  • San Mateo, CA

Work

Company: Stanford Blood/Marrow Transplnt Address: 300 Pasteur Dr Suite H0101, Stanford, CA 94305 Phones: (650) 723-0822

Education

School / High School: McGill University / Faculty of Medicine

Languages

English

Emails

b***[email protected]

Specialities

Hematology • Hematology & Oncology

Professional Records

Medicine Doctors

Robert Lowsky Photo 1

Dr. Robert Lowsky, Stanford CA - MD (Doctor of Medicine)

View page
Specialties:
Hematology
Hematology & Oncology
Address:
Stanford Blood/Marrow Transplnt
300 Pasteur Dr Suite H0101, Stanford, CA 94305
(650) 723-0822 (Phone)
Languages:
English
Hospitals:
Stanford Blood/Marrow Transplnt
300 Pasteur Dr Suite H0101, Stanford, CA 94305

Stanford Hospital and Clinics
300 Pasteur Drive, Stanford, CA 94305
Education:
Medical School
McGill University / Faculty of Medicine
Robert Lowsky Photo 2

Robert Lowsky

View page
Specialties:
Hematology/Oncology, Transplant Surgery
Work:
Stanford Hospital Blood & Marrow Transplant Program
300 Pasteur Dr RM H0101, Stanford, CA 94305
(650) 723-0822 (phone), (650) 725-8950 (fax)
Education:
Medical School
McGill University Faculty of Medicine, Montreal, Canada
Graduated: 1988
Procedures:
Bone Marrow Biopsy
Bone Marrow or Stem Cell Transplant
Conditions:
Anemia
Chronic Renal Disease
Hodgkin's Lymphoma
Leukemia
Malignant Neoplasm of Female Breast
Languages:
English
Description:
Dr. Lowsky graduated from the McGill University Faculty of Medicine, Montreal, Canada in 1988. He works in Stanford, CA and specializes in Hematology/Oncology and Transplant Surgery. Dr. Lowsky is affiliated with Stanford Hospital.

Business Records

Name / Title
Company / Classification
Phones & Addresses
Robert Lowsky
Robert Lowsky MD
Internist
300 Pasteur Dr, Stanford, CA 94305
(650) 723-9729

Publications

Us Patents

Enhancement Of Allogeneic Hematopoietic Stem Cell Transplantation

View page
US Patent:
20120177621, Jul 12, 2012
Filed:
Jan 10, 2012
Appl. No.:
13/347452
Inventors:
Samuel Strober - Stanford CA, US
Suparna Dutt - Palo Alto CA, US
Robert Lowsky - Stanford CA, US
International Classification:
A61K 35/12
A61P 35/02
A61P 35/00
US Classification:
424 9371
Abstract:
Methods and compositions are provided to augment the conversion of mixed hematopoietic cell chimerism to complete donor cell chimerism following allogeneic hematopoietic cell transplantation (HCT), where such transplantation may be utilized for treatment of cancer such as leukemia and lymphoma or for other conditions requiring reconstitution of the hematopoietic system, e.g. treatment of anemias, thalassemias, autoimmune conditions, and the like. The present invention improves on conventional DLI by utilizing a composition of substantially purified donor memory CD8 T cells as DLI following allogeneic HCT, where the cells are administered at a suitable time following transplantation. The methods provide for a more complete donor chimerism, and have the further benefit of killing tumor cells without GVHD. The memory CD8+ T cells may include one or both of central and effector memory T cells, usually both.

Combined Organ And Hematopoietic Cells For Transplantation Tolerance Of Grafts

View page
US Patent:
20220362291, Nov 17, 2022
Filed:
Jul 25, 2022
Appl. No.:
17/872741
Inventors:
- Stanford CA, US
Robert Lowsky - Stanford CA, US
International Classification:
A61K 35/12
A61K 35/28
A61K 35/22
A61K 35/14
A61K 38/19
A61K 41/00
A61K 45/06
A61K 31/365
A61K 31/436
A61K 31/573
A61K 38/13
A61K 39/00
A61K 39/395
A61N 5/10
A61K 35/17
Abstract:
Methods and compositions are provided for combined transplantation of a solid organ and hematopoietic cells to a recipient, where tolerance to the graft is established through development of a persistent mixed chimerism. An individual with persistent mixed chimerism, usually for a period of at least six months, is able to withdraw from the use of immunosuppressive drugs after a period of time sufficient to establish tolerance.

Combined Organ And Hematopoietic Cells For Transplantation Tolerance Of Hla Mismatched Grafts

View page
US Patent:
20200254015, Aug 13, 2020
Filed:
Dec 20, 2019
Appl. No.:
16/723840
Inventors:
- Stanford CA, US
Robert Lowsky - Stanford CA, US
International Classification:
A61K 35/12
A61K 35/17
A61N 5/10
A61K 39/395
A61K 39/00
A61K 38/13
A61K 31/573
A61K 31/436
A61K 31/365
A61K 45/06
A61K 41/00
A61K 38/19
A61K 35/14
A61K 35/22
A61K 35/28
Abstract:
Methods and compositions are provided for combined transplantation of a solid organ and hematopoietic cells to an HLA mismatched recipient, where tolerance to the graft is established through development of a persistent mixed chimerism. An individual with persistent mixed chimerism, usually for a period of at least six months, is able to withdraw from the use of immunosuppressive drugs after a period of time sufficient to establish tolerance.

Combined Organ And Hematopoietic Cells For Transplantation Tolerance Of Grafts

View page
US Patent:
20190358257, Nov 28, 2019
Filed:
Jul 18, 2019
Appl. No.:
16/515897
Inventors:
- Stanford CA, US
Robert Lowsky - Stanford CA, US
International Classification:
A61K 35/12
A61K 35/22
A61K 35/14
A61K 35/28
A61K 39/395
A61N 5/10
A61K 38/13
A61K 31/573
A61K 31/365
A61K 39/00
A61K 35/17
A61K 38/19
A61K 41/00
A61K 45/06
A61K 31/436
Abstract:
Methods and compositions are provided for combined transplantation of a solid organ and hematopoietic cells to a recipient, where tolerance to the graft is established through development of a persistent mixed chimerism. An individual with persistent mixed chimerism, usually for a period of at least six months, is able to withdraw from the use of immunosuppressive drugs after a period of time sufficient to establish tolerance.

Combined Organ And Hematopoietic Cells For Transplantation Tolerance Of Grafts

View page
US Patent:
20190336528, Nov 7, 2019
Filed:
Jul 18, 2019
Appl. No.:
16/515955
Inventors:
- Stanford CA, US
Robert Lowsky - Stanford CA, US
International Classification:
A61K 35/12
A61K 35/22
A61K 35/14
A61K 35/28
A61K 39/395
A61N 5/10
A61K 38/13
A61K 31/573
A61K 31/365
A61K 39/00
A61K 35/17
A61K 38/19
A61K 41/00
A61K 45/06
A61K 31/436
Abstract:
Methods and compositions are provided for combined transplantation of a solid organ and hematopoietic cells to a recipient, where tolerance to the graft is established through development of a persistent mixed chimerism. An individual with persistent mixed chimerism, usually for a period of at least six months, is able to withdraw from the use of immunosuppressive drugs after a period of time sufficient to establish tolerance.

Combined Organ And Hematopoietic Cells For Transplantation Tolerance Of Grafts

View page
US Patent:
20190298762, Oct 3, 2019
Filed:
Jun 20, 2019
Appl. No.:
16/447691
Inventors:
- Stanford CA, US
Robert Lowsky - Stanford CA, US
International Classification:
A61K 35/12
A61K 35/22
A61K 35/28
A61K 39/395
A61N 5/10
A61K 38/13
A61K 31/573
A61K 31/436
A61K 45/06
A61K 41/00
A61K 38/19
A61K 35/14
A61K 35/17
A61K 39/00
A61K 31/365
Abstract:
Methods and compositions are provided for combined transplantation of a solid organ and hematopoietic cells to a recipient, where tolerance to the graft is established through development of a persistent mixed chimerism. An individual with persistent mixed chimerism, usually for a period of at least six months, is able to withdraw from the use of immunosuppressive drugs after a period of time sufficient to establish tolerance.

Combined Organ And Hematopoietic Cells For Transplantation Tolerance Of Grafts

View page
US Patent:
20190192561, Jun 27, 2019
Filed:
Mar 4, 2019
Appl. No.:
16/291477
Inventors:
- Stanford CA, US
Robert Lowsky - Stanford CA, US
International Classification:
A61K 35/12
A61K 35/22
A61K 35/28
A61K 39/395
A61N 5/10
A61K 38/13
A61K 31/573
A61K 31/436
A61K 45/06
A61K 41/00
A61K 38/19
A61K 35/14
A61K 35/17
A61K 39/00
A61K 31/365
Abstract:
Methods and compositions are provided for combined transplantation of a solid organ and hematopoietic cells to a recipient, where tolerance to the graft is established through development of a persistent mixed chimerism. An individual with persistent mixed chimerism, usually for a period of at least six months, is able to withdraw from the use of immunosuppressive drugs after a period of time sufficient to establish tolerance.

Combined Organ And Hematopoietic Cells For Transplantation Tolerance Of Grafts

View page
US Patent:
20190192562, Jun 27, 2019
Filed:
Mar 4, 2019
Appl. No.:
16/291492
Inventors:
- Stanford CA, US
Robert Lowsky - Stanford CA, US
International Classification:
A61K 35/12
A61K 35/22
A61K 35/28
A61K 39/395
A61N 5/10
A61K 38/13
A61K 31/573
A61K 31/436
A61K 45/06
A61K 41/00
A61K 38/19
A61K 35/14
A61K 35/17
A61K 39/00
A61K 31/365
Abstract:
Methods and compositions are provided for combined transplantation of a solid organ and hematopoietic cells to a recipient, where tolerance to the graft is established through development of a persistent mixed chimerism. An individual with persistent mixed chimerism, usually for a period of at least six months, is able to withdraw from the use of immunosuppressive drugs after a period of time sufficient to establish tolerance.
Control profile
Robert L Lowsky from Belmont, CA, age ~64 Get Report